FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971297092> ?p ?o ?g. }

• W1971297092 endingPage "355" @default.
• W1971297092 startingPage "341" @default.
• W1971297092 abstract "Catecholamine depletion with alpha-methylparatyrosine (AMPT) has previously been shown to induce depressive symptoms in currently remitted patients with major depressive disorder (MDD) but not healthy controls. Thus sensitivity to catecholamine depletion has been hypothesized to be an endophenotype of MDD. Here we tested this hypothesis in the context of a randomized, double-blinded, placebo-controlled design by measuring changes in mood in a group of psychiatrically-healthy individuals at risk of mood disorders by virtue of family history (high-risk subjects, HRs). In addition, we tested whether HRs differed from healthy controls with no family-history of mood disorders (low-risk controls, LRs) in their cerebral metabolic response when undergoing catecholamine depletion. Eight healthy LRs (6 males, mean age = 34.1 ± 7.1) and 6 healthy HRs (3 males, mean age = 29.3 ± 4.6) participated in two, 3-day-long identical sessions during which they completed standardized measures of depression, anxiety and fatigue and an [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) scan. On one occasion participants received 4 weight-adjusted doses of AMPT and on the other occasion participants received 4 doses of placebo. The LR and HR groups did not differ from each other in their mood during sham depletion. However, during the period of peak catecholamine depletion, the HR group reported significantly more depression, anxiety and fatigue than the LR group. A region-of-interest analysis showed that during catecholamine depletion versus placebo the combined LR and HR groups displayed a significant increase in cerebral metabolic rate in the left and right ventral striata, left and right amygdalae, and left and right hippocampi (FWE-corrected p < 0.05). Whole brain voxel-wise analyses indicated significantly increased glucose metabolism in the left and right putamina (FWE-corrected p < 0.05) in the combined LR and HR groups in the AMPT versus the placebo session. In the LR group, alone, no significant elevation in glucose metabolism was observed in the regions-of-interest in the catecholamine depletion versus placebo condition. In the HR group, alone, the region-of-interest analysis showed a significant increase in cerebral metabolic rate in the left and right ventral striata (FWE-corrected p < 0.05). No regions-of-interest showed significantly different metabolism in the HR group versus the LR group in the placebo condition, however compared with the LR group, the HR group displayed nominally increased glucose metabolism in the left amygdala during catecholamine depletion (SVC-corrected p = 0.05). A region-of-interest analysis for the interaction contrast confirmed that catecholamine depletion had differential effects on HR and LR participants. Compared with the LR group, the HR group displayed significantly increased glucose metabolism in the left ventral striatum, left amygdala, and left lateral orbitofrontal cortex (OFC) (FWE-corrected p < 0.05). Our results suggest that sensitivity to catecholamine depletion may be a phenotypic marker of vulnerability to mood disorders that is characterized at the neurophysiological level by disinhibition of the striatum and its efferent projections comprising the limbic–cortical–striatal–pallidal–thalamic circuitry." @default.
• W1971297092 created "2016-06-24" @default.
• W1971297092 creator A5018534461 @default.
• W1971297092 creator A5029257842 @default.
• W1971297092 creator A5041065135 @default.
• W1971297092 creator A5055089575 @default.
• W1971297092 creator A5065976774 @default.
• W1971297092 creator A5086133175 @default.
• W1971297092 creator A5086346905 @default.
• W1971297092 creator A5087398056 @default.
• W1971297092 date "2013-01-01" @default.
• W1971297092 modified "2023-10-16" @default.
• W1971297092 title "Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [18F]fluorodeoxyglucose positron emission tomography study" @default.
• W1971297092 cites W1529162622 @default.
• W1971297092 cites W1588260775 @default.
• W1971297092 cites W1594873916 @default.
• W1971297092 cites W1607171655 @default.
• W1971297092 cites W1852183102 @default.
• W1971297092 cites W1927369345 @default.
• W1971297092 cites W1969852349 @default.
• W1971297092 cites W1971315623 @default.
• W1971297092 cites W1971880874 @default.
• W1971297092 cites W1972599491 @default.
• W1971297092 cites W1975511880 @default.
• W1971297092 cites W1977421115 @default.
• W1971297092 cites W1978341871 @default.
• W1971297092 cites W1981590577 @default.
• W1971297092 cites W1982844998 @default.
• W1971297092 cites W1984318946 @default.
• W1971297092 cites W1990454576 @default.
• W1971297092 cites W1995362640 @default.
• W1971297092 cites W1996180426 @default.
• W1971297092 cites W1997018309 @default.
• W1971297092 cites W2001775440 @default.
• W1971297092 cites W2002716918 @default.
• W1971297092 cites W2003559037 @default.
• W1971297092 cites W2011620025 @default.
• W1971297092 cites W2026522842 @default.
• W1971297092 cites W2026586986 @default.
• W1971297092 cites W2029280276 @default.
• W1971297092 cites W2029997745 @default.
• W1971297092 cites W2036814814 @default.
• W1971297092 cites W2039646168 @default.
• W1971297092 cites W2044919198 @default.
• W1971297092 cites W2046746010 @default.
• W1971297092 cites W2049383085 @default.
• W1971297092 cites W2049477559 @default.
• W1971297092 cites W2054242592 @default.
• W1971297092 cites W2061876633 @default.
• W1971297092 cites W2062503636 @default.
• W1971297092 cites W2065360467 @default.
• W1971297092 cites W2070628135 @default.
• W1971297092 cites W2077319168 @default.
• W1971297092 cites W2080557402 @default.
• W1971297092 cites W2086876322 @default.
• W1971297092 cites W2091864444 @default.
• W1971297092 cites W2093456810 @default.
• W1971297092 cites W2094508177 @default.
• W1971297092 cites W2095447564 @default.
• W1971297092 cites W2096933190 @default.
• W1971297092 cites W2114613490 @default.
• W1971297092 cites W2121178670 @default.
• W1971297092 cites W2122384242 @default.
• W1971297092 cites W2123719127 @default.
• W1971297092 cites W2128563899 @default.
• W1971297092 cites W2131823335 @default.
• W1971297092 cites W2146747402 @default.
• W1971297092 cites W2147351252 @default.
• W1971297092 cites W2163132131 @default.
• W1971297092 cites W2171132931 @default.
• W1971297092 cites W287281448 @default.
• W1971297092 cites W3127623214 @default.
• W1971297092 doi "https://doi.org/10.1016/j.nicl.2013.02.004" @default.
• W1971297092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3778263" @default.
• W1971297092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24179788" @default.
• W1971297092 hasPublicationYear "2013" @default.
• W1971297092 type Work @default.
• W1971297092 sameAs 1971297092 @default.
• W1971297092 citedByCount "3" @default.
• W1971297092 countsByYear W19712970922014 @default.
• W1971297092 countsByYear W19712970922017 @default.
• W1971297092 crossrefType "journal-article" @default.
• W1971297092 hasAuthorship W1971297092A5018534461 @default.
• W1971297092 hasAuthorship W1971297092A5029257842 @default.
• W1971297092 hasAuthorship W1971297092A5041065135 @default.
• W1971297092 hasAuthorship W1971297092A5055089575 @default.
• W1971297092 hasAuthorship W1971297092A5065976774 @default.
• W1971297092 hasAuthorship W1971297092A5086133175 @default.
• W1971297092 hasAuthorship W1971297092A5086346905 @default.
• W1971297092 hasAuthorship W1971297092A5087398056 @default.
• W1971297092 hasBestOaLocation W19712970921 @default.
• W1971297092 hasConcept C118552586 @default.
• W1971297092 hasConcept C126322002 @default.
• W1971297092 hasConcept C139719470 @default.
• W1971297092 hasConcept C142724271 @default.
• W1971297092 hasConcept C151730666 @default.
• W1971297092 hasConcept C15744967 @default.
• W1971297092 hasConcept C162324750 @default.

• next